| Literature DB >> 30197527 |
Dan Guo1, Yangqun Liu1, Changlin Han1, Zhiyao Chen1, Xiaohua Ye1.
Abstract
BACKGROUND: Routine non-therapeutic antimicrobial use and overcrowding in animal farming may facilitate the propagation of methicillin-resistant Staphylococcus aureus (MRSA). This study aimed to examine the carriage prevalence and phenotype-genotype characteristics of MRSA and methicillin-susceptible S. aureus isolated from pigs.Entities:
Keywords: Staphylococcus aureus; animals; antimicrobial susceptibility; livestock; molecular characterization; multidrug resistance
Year: 2018 PMID: 30197527 PMCID: PMC6112776 DOI: 10.2147/IDR.S173624
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Prevalence of S. aureus, MRSA, and MDRSA among 1,458 pigs in Jiangmen, China
| Characteristics | No. of samples (%) | MRSA
| MDRSA
| ||||
|---|---|---|---|---|---|---|---|
| n1 (%) | n2 (%) | n3 (%) | |||||
| Total | 1,458 (100.0) | 139 (9.5) | 48 (3.3) | 135 (9.3%) | |||
| Sample type | |||||||
| Farm pigs | 411 (28.2) | 28 (6.8) | 0.027 | 17 (4.1) | 0.258 | 28 (6.8) | 0.043 |
| Slaughterhouse pigs | 1,047 (71.8) | 111 (10.6) | 31 (3.0) | 107 (10.2) | |||
| Age group | |||||||
| Piglets (<3 months) | 194 (13.3) | 8 (4.1) | 0.006 | 5 (2.6) | 0.549 | 8 (4.1) | 0.215 |
| Grower pigs (≥3 months) | 1,264 (86.7) | 131 (10.4) | 43 (3.4) | 127 (6.4) | |||
Abbreviations: S. aureus, Staphylococcus aureus; MRSA, methicillin-resistant S. aureus; MDRSA, multidrug-resistant S. aureus; n1, number of S. aureus isolates; n2, number of MRSA isolates; n3, number of MDRSA isolates.
Antibiotic susceptibility and resistance genes of 139 Staphylococcus aureus isolates
| Phenotype (resistance) | Genotype (positive) | No. of positive isolates (%) |
|---|---|---|
| Clindamycin | 135 (97.1) | |
| Tetracycline | 134 (96.4) | |
| 81 (58.3) | ||
| 87 (62.6) | ||
| Erythromycin | 129 (92.8) | |
| 7 (5.0) | ||
| 110 (79.1) | ||
| Trimethoprim-sulfamethoxazole | 115 (82.7) | |
| Gentamicin | 65 (46.8) | |
| Chloramphenicol | 87 (62.6) | |
| Cefoxitin | 87 (62.6) | |
| Rifampin | 51 (36.7) | |
| Ciprofloxacin | 47 (33.8) | |
| Quinupristin-dalfopristin | 17 (12.2) | |
| Linezolid | 9 (6.5) |
Figure 1Heat map showing antibiotic resistance profiles of all multidrug-resistant S. aureus isolates.
Abbreviations: CLI, clindamycin; TET, tetracycline; ERY, erythromycin; SXT, trimethoprim-sulfamethoxazole; GEN, gentamicin; CHL, chloramphenicol; FOX, cefoxitin; RD, rifampin; CIP, ciprofloxacin; QD, quinupristin-dalfopristin; LZD, linezolid; S. aureus, Staphylococcus aureus.
Relationships between predominant CCs/STs and phenotype–genotype characteristics of S. aureus isolates
| CC/ST(n | Resistance phenotypes (non-susceptible)
| Resistance genes (positive)
| Virulence genes (positive)
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GEN | CIP | SXT | FOX | TET | QD | ERY | LZD | CHL | RD | CLI | |||||||||||
| 9 | 3 | 10 | 11 | 16 | 3 | 14 | 2 | 14 | 2 | 17 | 11 | 13 | 1 | 11 | 0 | 9 | 5 | 13 | 0 | 12 | |
| ST1(8) | 4 | 2 | 4 | 5 | 7 | 2 | 7 | 1 | 7 | 2 | 8 | 5 | 5 | 1 | 6 | 0 | 7 | 3 | 5 | 0 | 7 |
| 9 | 9 | 12 | 5 | 13 | 2 | 13 | 1 | 13 | 6 | 15 | 6 | 10 | 1 | 10 | 0 | 11 | 0 | 11 | 0 | 2 | |
| ST920(12) | 7 | 7 | 10 | 3 | 10 | 2 | 11 | 1 | 10 | 5 | 12 | 5 | 8 | 0 | 8 | 0 | 10 | 0 | 8 | 0 | 0 |
| 50 | 51 | 68 | 49 | 73 | 27 | 71 | 1 | 64 | 37 | 73 | 45 | 38 | 0 | 64 | 0 | 40 | 17 | 60 | 6 | 56 | |
| ST9(33) | 26 | 27 | 31 | 25 | 33 | 13 | 32 | 1 | 30 | 15 | 33 | 17 | 10 | 0 | 30 | 0 | 17 | 15 | 26 | 2 | 27 |
| ST2931(13) | 7 | 8 | 13 | 8 | 13 | 4 | 13 | 0 | 11 | 6 | 13 | 10 | 9 | 0 | 11 | 0 | 7 | 0 | 10 | 1 | 9 |
| ST2454(11) | 5 | 8 | 10 | 8 | 11 | 4 | 10 | 0 | 10 | 5 | 11 | 8 | 8 | 0 | 10 | 0 | 8 | 0 | 9 | 0 | 6 |
| 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 0 | 1 | 0 | 1 | 1 | 1 | |
| 1 | 1 | 2 | 1 | 2 | 1 | 3 | 0 | 1 | 1 | 3 | 1 | 3 | 0 | 1 | 0 | 2 | 0 | 2 | 0 | 1 | |
| 2 | 1 | 3 | 1 | 4 | 1 | 4 | 1 | 3 | 1 | 4 | 3 | 3 | 2 | 3 | 0 | 3 | 0 | 2 | 0 | 1 | |
| 1 | 1 | 2 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 2 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 1 | |
Notes: Values are expressed as number of isolates.
Number of S. aureus isolates.
Abbreviations: CC, clonal complexes; ST, sequence types; GEN, gentamicin; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; FOX, cefoxitin; TET, tetracycline; QD, quinupristin-dalfopristin; ERY, erythromycin; LZD, linezolid; CHL, chloramphenicol; RD, rifampin; CLI, clindamycin; S. aureus, Staphylococcus aureus.
Figure 2Correspondence analysis for the relationship between CC and resistance pattern (A) or number of virulence genes (B) of S. aureus isolates.
Abbreviations: PDR, pan-drug-resistant; MDR, multidrug-resistant; XDR, extensively drug-resistant; CC, clonal complex; S. aureus, Staphylococcus aureus.